MIT engineers have designed a new emergency implant to protect people with Type 1 diabetes from life-threatening hypoglycemia. The device, about the size of a quarter, sits under the skin and releases ...

Indianapolis-based pharma giant Eli Lilly has announced the company now offers an Android version of its app, called Glucagon, which is designed to help caregivers and providers treat people with ...

When a person with Type 1 diabetes develops severe hypoglycemia (more commonly known as low blood sugar), they turn to glucagon. This hormone, produced in limited quantities by the pancreas, orders ...

In transition-age childhood-onset growth hormone deficiency, growth hormone response to the glucagon stimulation test depends mainly on pituitary dysfunction severity, with BMI having minimal impact.